RayzeBio, Inc. Common Stock

RayzeBio, Inc. Common Stockverified

RYZB

Price:

$62.49

Market Cap:

$3.75B

RayzeBio, Inc. develops radiopharmaceutical therapeutics (RPT) for the treatment of cancer. The company’s lead drug candidate is RYZ101, which is in phase 3 clinical trial for the treatment of gasteroenteropancreatic neuroendocrine tumors (GEP-NETs). It also develops RYZ801, a novel proprietary peptide that targets GPC3 for delivery of Ac225 for the treatment of hepatocellular carcinoma (HCC); RYZ811, a paired diagnostic imaging agent with the peptide binder, chelator, and Ga68 as the radioisotope; and a novel proprietary small molecule that targets CA9 for delivery of Ac225 for the treatment of ccRCC. The company was incorporated in 2020 and is based in San Diego, California.

Industry

Biotechnology

IPO Date

2023-09-15

Stock Exchange

NASDAQ

Ticker

RYZB

The PE Ratio as of November 2025 (TTM) for RayzeBio, Inc. Common Stock (RYZB) is -57.86

According to RayzeBio, Inc. Common Stock’s latest financial reports and current stock price. The company's current PE Ratio is -57.86. This represents a change of 736.37% compared to the average of -6.92 of the last 4 quarters.

RayzeBio, Inc. Common Stock (RYZB) Historical PE Ratio (quarterly & annually)

How has RYZB PE Ratio performed in the past?

The mean historical PE Ratio of RayzeBio, Inc. Common Stock over the last ten years is -62.16. The current -57.86 PE Ratio has changed 9.21% with respect to the historical average. Over the past ten years (40 quarters), RYZB's PE Ratio was at its highest in in the June 2023 quarter at 0. The PE Ratio was at its lowest in in the September 2022 quarter at -11.83.

Quarterly (TTM)
Annual

Average

-62.16

Median

-32.86

Minimum

-139.89

Maximum

-13.72

RayzeBio, Inc. Common Stock (RYZB) PE Ratio by Quarter and Year

Discovering the peaks and valleys of RayzeBio, Inc. Common Stock PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual PE Ratio = -13.72

Minimum Annual Increase = -76.51%

Minimum Annual PE Ratio = -139.89

Quarterly (TTM)
Annual
YearPE RatioChange
2022-13.72-58.24%
2021-32.86-76.51%

RayzeBio, Inc. Common Stock (RYZB) Average PE Ratio

How has RYZB PE Ratio performed in the past?

The current PE Ratio of RayzeBio, Inc. Common Stock (RYZB) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-62.16

5-year avg

-62.16

10-year avg

-62.16

RayzeBio, Inc. Common Stock (RYZB) PE Ratio vs. Peers

How is RYZB’s PE Ratio compared to its peers?

RayzeBio, Inc. Common Stock’s PE Ratio is less than CymaBay Therapeutics, Inc. (-32.74), less than SpringWorks Therapeutics, Inc. (-13.86), less than Mirati Therapeutics, Inc. (-4.46), less than Opthea Limited (-1.15), greater than Alpine Immune Sciences, Inc. (-100.94), less than Morphic Holding, Inc. (-15.88), less than MorphoSys AG (-11.77), less than Chinook Therapeutics, Inc. (-14.08), less than Myovant Sciences Ltd. (-12.18), less than 1Life Healthcare, Inc. (-8.16),

Build a custom stock screener for RayzeBio, Inc. Common Stock (RYZB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like RayzeBio, Inc. Common Stock using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

RayzeBio, Inc. Common Stock (RYZB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like RayzeBio, Inc. Common Stock or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is RayzeBio, Inc. Common Stock's PE Ratio?

How is the PE Ratio calculated for RayzeBio, Inc. Common Stock (RYZB)?

What is the highest PE Ratio for RayzeBio, Inc. Common Stock (RYZB)?

What is the 3-year average PE Ratio for RayzeBio, Inc. Common Stock (RYZB)?

What is the 5-year average PE Ratio for RayzeBio, Inc. Common Stock (RYZB)?

How does the current PE Ratio for RayzeBio, Inc. Common Stock (RYZB) compare to its historical average?